from News-Economic Times https://ift.tt/37ncw6G
Home »
News-Economic Times
» Covaxin triggers immune response, no adverse effects in phase 1 trial
Covaxin triggers immune response, no adverse effects in phase 1 trial
Related Posts:
Commission on air pollution in NCR to shut down as ordinance lapsesThe Commission for Air Quality Management in National Capital Region and Adjoining Areas to tackle pollution in the Delhi airshed came into existence after President Ram Nath Kovind promulgated the ordinance on October 28. f… Read More
Quad to deliver up to 1 billion Covid-19 vaccine doses to Indo-Pacific region: USA from News-Economic Times https://ift.tt/3rNFYuk … Read More
India set to produce coronavirus vaccine under Quad initiative with US, Japan and AustraliaVaccines will be developed in the US, manufactured in India, financed by Japan and the US, and supported by Australia through logistics for the Indo-Pacific including island states, in a far-reaching move that could challenge… Read More
NewSpace India to invest Rs 10,000 crore to buy, run satellitesNewSpace India Ltd (NSIL), the commercial arm of Department of Space, is also in talks with ISRO to acquire its fleet of remote-sensing and communication satellites. from News-Economic Times https://ift.tt/3eyr6fJ … Read More
Finance Ministry writes to Sebi, 'requests' agency to withdraw perpetual bond ruleThe ministry's objection is to the rule that requires debt mutual funds to value perpetual bonds as a 100-year instrument from April 1. Fund managers too had raised concerns over this. from News-Economic Times https://ift.tt… Read More
0 Comments:
Post a Comment